Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04913233
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-06-04
First Post:
2021-05-30
Brief Title:
Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omics
Sponsor:
Second Affiliated Hospital School of Medicine Zhejiang University
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University
Study Overview
Official Title:
Research on New Technologies for Screening and Early Diagnosis of Malignant Tumors - Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omics
Status:
NOT_YET_RECRUITING
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background
The current screening techniques for colorectal cancer include colonoscopy fecal occult blood and high-risk factor questionnaires However the colorectal cancer screening technology that has been widely used at present cannot take into account sensitivity and specificity and the tumor detection rate is low
The purpose of research
1 Build a new type of population colorectal cancer precision screening technology program
2 Improve the detection rate of colorectal cancer in the population by new methods compared with the existing domestic advanced technology by 20 and improve the specificity of colorectal cancer screening by 15 without significantly reducing the sensitivity
The current screening techniques for colorectal cancer include colonoscopy fecal occult blood and high-risk factor questionnaires However the colorectal cancer screening technology that has been widely used at present cannot take into account sensitivity and specificity and the tumor detection rate is low
The purpose of research
1 Build a new type of population colorectal cancer precision screening technology program
2 Improve the detection rate of colorectal cancer in the population by new methods compared with the existing domestic advanced technology by 20 and improve the specificity of colorectal cancer screening by 15 without significantly reducing the sensitivity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None